Matches in Nanopublications for { ?s ?p "[Combination of NPM-ALK repression and CD30 ligand leads to significantly increased tumor cell growth inhibition compared with one method alone, suggesting its potential application for ALCL-specific cancer treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- assertion description "[Combination of NPM-ALK repression and CD30 ligand leads to significantly increased tumor cell growth inhibition compared with one method alone, suggesting its potential application for ALCL-specific cancer treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP689512.RA5MO8FyIu8Dk5GDTK1b0X6TFs7s4rub2wtMLqiCg_7_E130_assertion description "[Combination of NPM-ALK repression and CD30 ligand leads to significantly increased tumor cell growth inhibition compared with one method alone, suggesting its potential application for ALCL-specific cancer treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP689512.RA5MO8FyIu8Dk5GDTK1b0X6TFs7s4rub2wtMLqiCg_7_E130_provenance.
- NP923471.RA5_mbSzXpMNDUEvq32UMpB_xfuyh-IBaWmHexxRSb3y0130_assertion description "[Combination of NPM-ALK repression and CD30 ligand leads to significantly increased tumor cell growth inhibition compared with one method alone, suggesting its potential application for ALCL-specific cancer treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP923471.RA5_mbSzXpMNDUEvq32UMpB_xfuyh-IBaWmHexxRSb3y0130_provenance.
- NP292429.RAu7hPbUjRvNEsIg0rAXgw4_T_0qnrUIez-c1HyMBPEpo130_assertion description "[Combination of NPM-ALK repression and CD30 ligand leads to significantly increased tumor cell growth inhibition compared with one method alone, suggesting its potential application for ALCL-specific cancer treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP292429.RAu7hPbUjRvNEsIg0rAXgw4_T_0qnrUIez-c1HyMBPEpo130_provenance.
- NP292453.RA-wq8pyh1volaGDeZQ4IAtE4F9tBcdKJ-st-DmhFaChw130_assertion description "[Combination of NPM-ALK repression and CD30 ligand leads to significantly increased tumor cell growth inhibition compared with one method alone, suggesting its potential application for ALCL-specific cancer treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP292453.RA-wq8pyh1volaGDeZQ4IAtE4F9tBcdKJ-st-DmhFaChw130_provenance.
- NP292464.RA5Gypb6YOdiUkoJUZTWbbNtsUZkpsHKb6dNgWSzD2amw130_assertion description "[Combination of NPM-ALK repression and CD30 ligand leads to significantly increased tumor cell growth inhibition compared with one method alone, suggesting its potential application for ALCL-specific cancer treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP292464.RA5Gypb6YOdiUkoJUZTWbbNtsUZkpsHKb6dNgWSzD2amw130_provenance.
- NP569865.RA-FU66Sdzi-lVDtbtUnVW0XxivtHzrNRq48lt61jsIj4130_assertion description "[Combination of NPM-ALK repression and CD30 ligand leads to significantly increased tumor cell growth inhibition compared with one method alone, suggesting its potential application for ALCL-specific cancer treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP569865.RA-FU66Sdzi-lVDtbtUnVW0XxivtHzrNRq48lt61jsIj4130_provenance.